Nosa Med AB (NOSA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nosa Med AB (NOSA) has a cash flow conversion efficiency ratio of -0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.26 Million ≈ $-243.32K USD) by net assets (Skr41.71 Million ≈ $4.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nosa Med AB - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Nosa Med AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NOSA total debt and obligations for a breakdown of total debt and financial obligations.
Nosa Med AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nosa Med AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blue Sky Uranium Corp
V:BSK
|
1.543x |
|
INCREDIBLE INDUSTRIES LIMITED
NSE:INCREDIBLE
|
0.019x |
|
Vichitbhan Palmoil Public Company Limited
BK:VPO
|
0.229x |
|
Pinehill Pacific Bhd
KLSE:1902
|
-0.213x |
|
Intelligent Protection Management Corp
NASDAQ:IPM
|
0.007x |
|
Rectitude Holdings Ltd Ordinary Shares
NASDAQ:RECT
|
-0.063x |
|
KAP AG
F:IUR
|
0.002x |
|
Wicaksana Overseas International
JK:WICO
|
0.087x |
Annual Cash Flow Conversion Efficiency for Nosa Med AB (2016–2024)
The table below shows the annual cash flow conversion efficiency of Nosa Med AB from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Nosa Med AB market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr16.56 Million ≈ $1.78 Million |
Skr-10.03 Million ≈ $-1.08 Million |
-0.606x | +7.42% |
| 2023-12-31 | Skr26.75 Million ≈ $2.88 Million |
Skr-17.50 Million ≈ $-1.88 Million |
-0.654x | -73.15% |
| 2022-12-31 | Skr18.34 Million ≈ $1.97 Million |
Skr-6.93 Million ≈ $-745.46K |
-0.378x | -137.98% |
| 2021-12-31 | Skr39.10 Million ≈ $4.21 Million |
Skr-6.21 Million ≈ $-668.08K |
-0.159x | +76.94% |
| 2020-12-31 | Skr101.64 Million ≈ $10.94 Million |
Skr-69.96 Million ≈ $-7.53 Million |
-0.688x | -145.24% |
| 2019-12-31 | Skr187.85 Million ≈ $20.22 Million |
Skr-52.72 Million ≈ $-5.67 Million |
-0.281x | -60.30% |
| 2018-12-31 | Skr200.39 Million ≈ $21.56 Million |
Skr-35.09 Million ≈ $-3.78 Million |
-0.175x | -21.13% |
| 2017-12-31 | Skr192.22 Million ≈ $20.69 Million |
Skr-27.78 Million ≈ $-2.99 Million |
-0.145x | -3.44% |
| 2016-12-31 | Skr168.06 Million ≈ $18.09 Million |
Skr-23.48 Million ≈ $-2.53 Million |
-0.140x | -- |
About Nosa Med AB
Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, rest of Europe, the United States, Canada, and internationally. The company offers NOSA allergy filter that filters airborne allergens, such as pollen, pet dander, dust, and mold; NOSA smell training, a smell training medical device to improve the sense of smell for individuals … Read more